Q4 2025 OrthoPediatrics Corp Earnings Call Transcript

Feb 26, 2026 / 09:30 PM GMT

Release Date Price: €13.8 (+2.99%)

Transcript 10-K8-K

Key Points

Positve

OrthoPediatrics Corp (KIDS) reported a 17% revenue growth in Q4 2025, marking a strong close to the year.
The company achieved its first quarter of positive free cash flow, generating $10 million in Q4 2025.
OrthoPediatrics Corp (KIDS) launched a series of technologically advanced products, including the 3P hip system and Vertiglide, which are expected to drive future growth.
The company received FDA approval for the 3P Small Mini system, expanding its product offerings.
International revenue grew by 33% in Q4 2025, indicating strong global demand for OrthoPediatrics Corp (KIDS)'s products.

Negative

Despite revenue growth, OrthoPediatrics Corp (KIDS) reported a GAAP net loss per share of $0.43 for Q4 2025.
Operating expenses increased by 7% in Q4 2025, driven by higher sales and marketing costs.
The company's research and development expenses decreased, raising concerns about potential impacts on future product innovation.
There is competitive pressure in the scoliosis segment, which could impact market share.
The company's expansion into non-orthopedic areas, such as cardiovascular, may present challenges in maintaining profitability and focus.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

KIDS.OQ - Orthopediatrics Corp
Q4 2025 OrthoPediatrics Corp Earnings Call
Feb 26, 2026 / 09:30PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Good afternoon and welcome to Ortho.

Welcome to Ortho Pediatrics Corporation's 4th quarter 2025 conference call. At this time, all participants are in listen-only mode. We will be facilitating a question-and-answer session towards the end of today's call.

After, as a reminder, this call is being recorded for replay purposes. I would now like to turn the call over to Trip Taylor, Investor relations, for a few introductory comments.

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------
Thank you for joining today's call. With me from the company are David Bailey,

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

7-Day Free Trial · Cancel Anytime

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.